Heimdall Insights

Global Multiple Myeloma Therapeutics Market

Sizing, Segmentation, & Growth Forecast (2025-2030)

Last updated: July 2026

Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.

Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).

1. Summary

The Global Multiple Myeloma Therapeutics Market was valued at $28.5 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 6.8% CAGR, to an estimated market size of $39.6 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The global multiple myeloma therapeutics market encompasses the research, development, and commercialization of pharmaceutical treatments and clinical procedures designed to manage malignant plasma cell proliferation. The scope includes targeted therapies (monoclonal antibodies, proteasome inhibitors), immunomodulatory drugs (IMiDs), CAR T-cell therapies, chemotherapy, and supportive care, while excluding general oncology diagnostics not specific to hematological malignancies.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Multiple Myeloma Therapeutics Market in the period 2025-30:

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:

Geographies

  • North America
  • Europe
  • Asia-Pacific
  • Rest of World

Segments

  • Targeted Therapies (mAbs & PIs)
  • Immunomodulatory Drugs (IMiDs)
  • CAR-T & Cell-based Therapies
  • Chemotherapy & Others